It is a business services public limited company based in Bangalore, Karnataka, India, established in 2003.
2003 | Bangalore, Karnataka, India | Under LiquidationI-Ven Biotech Limited, a under liquidation public limited company, was established on 16 December 2003 in Bangalore, Karnataka, India. it holds CIN: U02421KA2003PLC033026. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Sadhana Ramakant Shinde (Director), Jignesh Kamalkant Vasavada (Nominee Director), Rajesh Gopalkrishna Pai (Nominee Director). Past directors included Sadhana Ramakant Shinde, Suresh Shivanna Tumkur, Aluri Rao Srinivasa. Its latest AGM occurred on 27 July 2020, with the balance sheet filed on 31 March 2020. It is based at 23/4, Prestige Takt, 3Rd Floor Kasturba Road Cross, Bangalore, Karnataka, 560001.
U02421KA2003PLC033026
033026
16 December 2003
₹1.00 M
₹0.50 M
Roc Bangalore
Unlisted
Under Liquidation
Explore comprehensive insights into I-Ven Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sadhana Ramakant Shinde | Director | 01 Aug 2018 | Current |
| Jignesh Kamalkant Vasavada | Nominee Director | 31 Oct 2018 | Current |
| Rajesh Gopalkrishna Pai | Nominee Director | 12 May 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Aug 2018 | Past |
| Pramod Abcsdd | Director | 01 Aug 2018 | Past |
| Pramod Abcsdd | Director | 07 Apr 2008 | Past |
| Pramod Abcsdd | Director | 12 May 2014 | Past |
| Pramod Abcsdd | Nominee Director | 15 Mar 2016 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
I-Ven Biotech Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, I-Ven Biotech had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with I-Ven Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of I-Ven Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped I-Ven Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on I-Ven Biotech Limited last Annual general meeting of members was held on 27 Jul 2020 as per latest MCA records. was documented.
I-Ven Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Bangalore. was recorded as a recent event.
Progress on Jignesh Kamalkant Vasavada was appointed as a Nominee Director was appointed as a Nominee Director on 31 Oct 2018 & has been associated with this company since 7 years 28 days . was documented.
Progress on Sadhana Ramakant Shinde was appointed as a Director was appointed as a Director on 01 Aug 2018 & has been associated with this company since 7 years 3 months . was documented.
The activity Rajesh Gopalkrishna Pai was appointed as a Nominee Director was appointed as a Nominee Director on 12 May 2014 & has been associated with this company since 11 years 6 months . was completed.
Progress on I-Ven Biotech Limited was registered on 16 Dec 2003 with Roc Bangalore & aged 21 years 11 months as per MCA records. was documented.
The CIN of I-Ven Biotech Limited is U02421KA2003PLC033026.
I-Ven Biotech Limited is headquartered at 23/4, Prestige Takt, 3Rd Floor Kasturba Road Cross, Bangalore, Karnataka, 560001.
I-Ven Biotech Limited was incorporated on 16 December 2003.
The current directors of I-Ven Biotech Limited are
I-Ven Biotech Limited is unlisted.
The authorized capital of I-Ven Biotech Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of I-Ven Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX